Abstract
Carteolol, a nonselective beta-adrenergic antagonist with intrinsic sympathomimetic activity, was compared in 1% and 2% topical solutions with 0.5% timolol in 105 patients with primary open-angle glaucoma. In this double-masked, randomized 3-month trial, all three preparations significantly lowered intraocular pressure throughout the study, with no significant differences being observed. There were also no significant differences among the three preparations with regard to ocular or systemic adverse reactions, including heart rate and blood pressure.
Offprint requests to: M.B. Shields
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen RC, Hertzmark E, Walker AM, Epstein DL (1986) A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma. Am J Ophthalmol 101: 535–541
Brazier DJ, Smith SE (1988) Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers. Br J Ophthalmol 72:101–103
Duff GR, Newcombe RG (1988) The 12-hour control of intraocular pressure on carteolol 2% twice daily. Br J Ophthalmol 72:890–891
Flury H, Tournoux A, Martenet AC (1986) Tolerance and pharmacological actions of anti-glaucoma eye drops. Klin Monatsbl Augenheilkd 188:573–575
Harris LS, Greenstein SH, Bloom AF (1986) Respiratory difficulties with betaxolol. Am J Ophthalmol 102:274–275
Hugues FC, LeJeunne CL, Munera Y, Dufier JL (1987) Comparison of the effects of eyewashes with carteolol and metipranolol on the ventilatory and cardiovascular function in asthmatic patients. J Fr Ophthalmol 10:485–490
Kitazawa Y, Azuma I, Takase M, Komemushi S (1981) Ocular hypotensive effects of carteolol hydrochloride in primary openangle glaucoma and ocular hypertensive patients — a double-masked cross-over study for the determination of concentrations optimal for the clinical use. Nippon Ganka Gakkai Zasshi 85:798–804
Kitazawa Y, Azuma T, Takase M (1983) Evaluation of pharmacological effect of carteolol eyedrops against primary corneal open-angle glaucoma and high intraocular pressure diseases. Igaku No Ayumi 127:860–880
LeJeunne CL, Bringer L, Mondjee-Tahura Z, Munera Y, Hugues FC (1988) Cardiovascular effects of eye drops containing timolol, carteolol, metipranolol, and betaxolol in elderly patients. Therapie 43:89–92
Long DA, Johns GE, Mullen RS (1988) Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure. Ophthalmology 95:735–741
Negishi C, Kanai A, Nakajima A, Funahashi M, Kitazawa Y (1981) Ocular effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients. Jpn J Ophthalmol 25:464–476
Sano Y, Murakami S, Kudo K (1984) The effects of beta-blocker eyedrops on bronchial asthma — comparison of carteolol and timolol. Gandai Iryo 16:1259–1263
Scoville B, Krieglstein GK, Then E, Yokoyama S, Yokoyama T (1985) Measuring drug-induced eye irritation: a simple new clinical assay. J Clin Pharmacol 25:210–218
Scoville B, Mueller B, White BG, Krieglstein GK (1988) A double-masked comparison of carteolol and timolol in ocular hypertension. Am J Ophthalmol 105:150–154
Van Buskirk EM, Fraunfelder FT (1984) Ocular beta-blockers and systemic effects. Am J Ophthalmol 98:623–624
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steward, W.C., Shields, M.B., Allen, R.C. et al. A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma. Graefe's Arch Clin Exp Ophthalmol 229, 258–261 (1991). https://doi.org/10.1007/BF00167880
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00167880